About Dr. Liu Jianmin
Dr. Liu Jianmin (刘建民) is one of China's foremost endocrinologists and a nationally recognized authority on pituitary disease, adrenal disorders, and neuroendocrine tumors. He serves as Director of the Pituitary and Adrenal Disease Center within the Department of Endocrinology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, and holds the title of Chief Physician and Professor.
Working alongside the legendary Academician Ning Guang, Dr. Liu has established himself as China's leading specialist in the diagnosis and management of complex pituitary and adrenal conditions — a highly specialized niche where accurate diagnosis is notoriously difficult and where misdiagnosis or delayed treatment can have devastating consequences. His expertise in Cushing's syndrome, acromegaly, pituitary adenomas, and primary aldosteronism is unmatched in China, and he is regularly consulted on the most complex and diagnostically challenging cases from across the country and internationally.
International patients with suspected or confirmed pituitary or adrenal disease — including those who have received conflicting diagnoses or inadequate treatment overseas — consistently identify Dr. Liu as one of the world's top specialists to consult for these conditions.
Professional Positions and Affiliations
- Director, Pituitary and Adrenal Disease Center, Department of Endocrinology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Chairman, Pituitary Disease Committee, Chinese Society of Endocrinology
- Vice Chairman, Adrenal Disease Committee, Chinese Society of Endocrinology
- Editorial Board Member: European Journal of Endocrinology, Clinical Endocrinology, Journal of Clinical Endocrinology and Metabolism (JCEM)
- Member, European Society of Endocrinology (ESE)
- Member, Endocrine Society (USA)
- Member, Pituitary Society
Specialties and Clinical Expertise
- Cushing's Syndrome and Cushing's Disease — comprehensive biochemical workup (UFC, late-night salivary cortisol, LDDST, HDDST, CRH stimulation test), inferior petrosal sinus sampling (IPSS) for ACTH source localization, pituitary MRI interpretation, and adrenal CT; medical therapy (ketoconazole, metyrapone, osilodrostat, pasireotide) and coordination with neurosurgery for transsphenoidal surgery
- Acromegaly — IGF-1 and GH suppression testing, pituitary MRI, somatostatin analog therapy (octreotide LAR, lanreotide), pegvisomant, and coordination with neurosurgery and radiation oncology
- Pituitary Adenomas — non-functioning adenomas, prolactinomas (dopamine agonist therapy), TSH-secreting adenomas, and plurihormonal adenomas; visual field assessment and ophthalmology coordination
- Primary Aldosteronism — aldosterone-to-renin ratio screening, confirmatory testing (fludrocortisone suppression, saline infusion), adrenal vein sampling (AVS) for lateralization, and medical vs. surgical management
- Pheochromocytoma and Paraganglioma — biochemical diagnosis (plasma/urine metanephrines), functional imaging (MIBG, Ga-68 DOTATATE PET), genetic testing, and perioperative management
- Adrenal Incidentaloma — systematic workup for hormonal excess and malignancy; surveillance vs. surgical referral decision-making
- Adrenal Insufficiency — primary (Addison's disease) and secondary adrenal insufficiency; glucocorticoid replacement optimization and sick day rules
- Neuroendocrine Tumors (NETs) — gastroenteropancreatic NETs; somatostatin analog therapy, PRRT coordination, and multidisciplinary management
Academic and Research Contributions
Dr. Liu Jianmin has published over 200 peer-reviewed papers in leading international endocrinology journals, with a particular focus on the epidemiology and clinical features of Cushing's syndrome in Chinese patients, the optimization of adrenal vein sampling techniques, and the long-term outcomes of pituitary surgery. His landmark research on the prevalence of primary aldosteronism in Chinese hypertensive patients — demonstrating that it is significantly underdiagnosed — has been widely cited and has influenced national screening guidelines.
He has led multicenter studies on the diagnostic accuracy of inferior petrosal sinus sampling in Chinese Cushing's disease patients and has contributed pivotal data on the efficacy of osilodrostat (a novel cortisol synthesis inhibitor) in Chinese patients. He is a regular invited speaker at the European Congress of Endocrinology (ECE), the Endocrine Society Annual Meeting (ENDO), and the Pituitary Society annual workshop.
Why International Patients Choose Dr. Liu Jianmin
- China's leading pituitary and adrenal specialist — Chairman of China's national pituitary disease committee
- Cushing's syndrome diagnostic expertise — one of the most diagnostically challenging conditions in endocrinology; Dr. Liu's experience is unmatched in China
- Adrenal vein sampling (AVS) expertise — the gold standard for primary aldosteronism lateralization, performed at high volume at Ruijin
- Access to novel therapies — osilodrostat, pasireotide, and other agents through clinical trials
- ESE and Endocrine Society member — aligned with international endocrinology standards
- Second opinion authority — regularly reviews complex overseas cases where diagnosis or treatment has been uncertain
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
- Appointment Lead Time: 2″4 weeks for new patients; complex diagnostic workups may require multiple visits
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Pre-consultation: Overseas hormonal lab results, imaging, and prior workup can be reviewed remotely through CMCS
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking consultation with Dr. Liu Jianmin at Ruijin Hospital. Our services include priority appointment booking, medical record and laboratory result translation, remote pre-consultation review, on-site interpretation during consultations and procedures, accommodation coordination, insurance liaison, and post-treatment follow-up with your home country endocrinologist.
📧 Contact us: contract@medicalsh.com
🌐 medicalsh.com
0 commenti